Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon alfa-2b + TDF in Chronic Hepatitis B
NCT04846491Phase 3Completed
- Sponsor
- Xiamen Tebao Biological Engineering Co., Ltd.
- Start
- Dec 2019
- Primary completion
- Nov 2023
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2b in Chronic Hepatitis B (CHB), sponsored by Xiamen Tebao Biological Engineering Co., Ltd.. Started Dec 2019; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT04846491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04846491.